Woodlawn, Canada

John Campbell

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: Abbott Point of Care Inc.. Active years: 2010-2017.


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 35(Granted Patents)


Location History:

  • Ottawa, CA (2010)
  • Woodlawn, CA (2014 - 2017)

Company Filing History:


Years Active: 2010-2017

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: John Campbell: Innovator in Point of Care Immunoassays

Introduction

John Campbell is a notable inventor based in Woodlawn, California. He has made significant contributions to the field of point of care immunoassays, holding a total of 4 patents. His work focuses on enhancing the accuracy and efficiency of diagnostic testing.

Latest Patents

One of John Campbell's latest patents is titled "Apparatus and method for identifying a hook effect and expanding the dynamic range in point of care immunoassays." This invention relates to systems and methods designed for the rapid in situ determination of the existence of a hook effect, which can adversely affect the results of immunoassays. The system includes a primary sensor with immobilized antibodies that generate a signal based on the presence of a target analyte in a sample. Additionally, an attenuated sensor with immobilized antibodies at a reduced concentration generates a second signal. A processor is configured to analyze these signals to determine the presence of a hook effect and optionally assess the target analyte concentration.

Career Highlights

John Campbell is currently employed at Abbott Point of Care Inc., where he continues to innovate in the field of medical diagnostics. His work has been instrumental in developing technologies that improve patient outcomes through more reliable testing methods.

Collaborations

Some of his notable coworkers include Rhonda Ade and Bruce Hendry, who contribute to the collaborative environment at Abbott Point of Care Inc. Their combined expertise enhances the development of cutting-edge diagnostic solutions.

Conclusion

John Campbell's contributions to point of care immunoassays exemplify the impact of innovation in medical technology. His patents and ongoing work continue to advance the field, ultimately benefiting healthcare providers and patients alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…